Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
[18F]Florzolotau in Alzheimer Disease: NCT07752784 Clinical Landscape Report 2026
9 min read
[18F]Florzolotau in Alzheimer Disease: NCT07752784 Clinical Landscape Report 2026
16 September 2026
NCT07752784 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Anifrolumab-FNIA in Systemic Lupus Erythematosus: NCT07751848 Clinical Landscape Report 2026
9 min read
Anifrolumab-FNIA in Systemic Lupus Erythematosus: NCT07751848 Clinical Landscape Report 2026
16 September 2026
NCT07751848 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Pemetrexed Disodium Hydrate in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07751536 Clinical Landscape Report 2026
9 min read
Pemetrexed Disodium Hydrate in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07751536 Clinical Landscape Report 2026
16 September 2026
NCT07751536 clinical landscape for Metastatic Malignant Neoplasm to the Leptomeninges: endpoints, sponsor, phase, geography, readouts, asset context and deve…
Read →
Tirzepatide in Pouchitis: NCT07756359 Clinical Landscape Report 2026
9 min read
Tirzepatide in Pouchitis: NCT07756359 Clinical Landscape Report 2026
16 September 2026
NCT07756359 clinical landscape for Pouchitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Apalutamide in Hormone-dependent prostate cancer: NCT07751133 Clinical Landscape Report 2026
9 min read
Apalutamide in Hormone-dependent prostate cancer: NCT07751133 Clinical Landscape Report 2026
16 September 2026
NCT07751133 clinical landscape for Hormone-dependent prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
Read →
Nogapendekin alfa inbakicept-pmln in Metastatic Prostate Carcinoma: NCT07756593 Clinical Landscape Report 2026
9 min read
Nogapendekin alfa inbakicept-pmln in Metastatic Prostate Carcinoma: NCT07756593 Clinical Landscape Report 2026
16 September 2026
NCT07756593 clinical landscape for Metastatic Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Albumin-Bound Paclitaxel in Non-Small Cell Lung Cancer: NCT07756645 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in Non-Small Cell Lung Cancer: NCT07756645 Clinical Landscape Report 2026
16 September 2026
NCT07756645 clinical landscape for Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Empagliflozin in Alzheimer Disease: NCT07756294 Clinical Landscape Report 2026
9 min read
Empagliflozin in Alzheimer Disease: NCT07756294 Clinical Landscape Report 2026
16 September 2026
NCT07756294 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
SYS-6020 in Multiple sclerosis relapse: NCT07756268 Clinical Landscape Report 2026
9 min read
SYS-6020 in Multiple sclerosis relapse: NCT07756268 Clinical Landscape Report 2026
16 September 2026
NCT07756268 clinical landscape for Multiple sclerosis relapse: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
SNV-1521 in Pancreatic Cancer: NCT07756281 Clinical Landscape Report 2026
9 min read
SNV-1521 in Pancreatic Cancer: NCT07756281 Clinical Landscape Report 2026
16 September 2026
NCT07756281 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Epoetin Alfa in Anemia in chronic kidney disease: NCT07755683 Clinical Landscape Report 2026
9 min read
Epoetin Alfa in Anemia in chronic kidney disease: NCT07755683 Clinical Landscape Report 2026
16 September 2026
NCT07755683 clinical landscape for Anemia in chronic kidney disease: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
AC-101 in Colitis, Ulcerative: NCT07755241 Clinical Landscape Report 2026
9 min read
AC-101 in Colitis, Ulcerative: NCT07755241 Clinical Landscape Report 2026
16 September 2026
NCT07755241 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →